Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CLOROX CO /DE/ Director's Dealing 2013

Nov 6, 2013

30403_dirs_2013-11-05_770c9110-4ddd-452b-85d8-5729d66bee81.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CLOROX CO /DE/ (CLX)
CIK: 0000021076
Period of Report: 2013-11-01

Reporting Person: TICKNOR CAROLYN M (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-11-01 Common Stock M 3900.0000 $59.0900 Acquired 3900.0000 Direct
2013-11-01 Common Stock S 3900.0000 $90.0039 Disposed 0.0000 Direct
2013-11-04 Common Stock M 3500.0000 $59.0900 Acquired 3500.0000 Direct
2013-11-04 Common Stock S 3500.0000 $90.0092 Disposed 0.0000 Direct
2013-11-05 Common Stock M 600.0000 $59.0900 Acquired 600.0000 Direct
2013-11-05 Common Stock S 600.0000 $90.0000 Disposed 0.0000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-02-15 Deferred Stock Units $ A 160.6258 Acquired Common Stock (160.6258) Direct
2013-05-10 Deferred Stock Units $ A 153.6153 Acquired Common Stock (153.6153) Direct
2013-08-09 Deferred Stock Units $ A 172.0200 Acquired Common Stock (172.0200) Direct
2013-11-01 Stock Option (Right to Buy) $59.0900 M 3900.0000 Disposed 2015-01-19 Common Stock (3900.0000) Direct
2013-11-04 Stock Option (Right to Buy) $59.0900 M 3500.0000 Disposed 2015-01-19 Common Stock (3500.0000) Direct
2013-11-05 Stock Option (Right to Buy) $59.0900 M 600.0000 Disposed 2015-01-19 Common Stock (600.0000) Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $90.00 to $90.03. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2: This transaction was executed in multiple trades at prices ranging from $90.00 to $90.04. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3: 1-for-1

F4: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.

F5: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.